Cargando…

Anthropometric Measurements and Frailty in Patients with Liver Diseases

There have been scarce data regarding the relationship between frailty and anthropometry measurements (AMs) in patients with chronic liver diseases (CLDs). We aimed to elucidate the influence of AMs on frailty in CLDs (median age = 66 years, 183 men and 192 women). AMs included arm circumference, tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Hiroki, Yoh, Kazunori, Enomoto, Hirayuki, Ikeda, Naoto, Aizawa, Nobuhiro, Koriyama, Takashi, Nishimura, Takashi, Nishiguchi, Shuhei, Iijima, Hiroko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344770/
https://www.ncbi.nlm.nih.gov/pubmed/32630551
http://dx.doi.org/10.3390/diagnostics10060433
_version_ 1783556022036594688
author Nishikawa, Hiroki
Yoh, Kazunori
Enomoto, Hirayuki
Ikeda, Naoto
Aizawa, Nobuhiro
Koriyama, Takashi
Nishimura, Takashi
Nishiguchi, Shuhei
Iijima, Hiroko
author_facet Nishikawa, Hiroki
Yoh, Kazunori
Enomoto, Hirayuki
Ikeda, Naoto
Aizawa, Nobuhiro
Koriyama, Takashi
Nishimura, Takashi
Nishiguchi, Shuhei
Iijima, Hiroko
author_sort Nishikawa, Hiroki
collection PubMed
description There have been scarce data regarding the relationship between frailty and anthropometry measurements (AMs) in patients with chronic liver diseases (CLDs). We aimed to elucidate the influence of AMs on frailty in CLDs (median age = 66 years, 183 men and 192 women). AMs included arm circumference, triceps skinfold thickness, calf circumference (CC), waist circumference, and body mass index. Frailty assessment was done by using five phenotypes (body weight loss, exhaustion, decreased muscle strength, slow walking speed, and low physical activity). Robust (frailty point 0), prefrail (frailty point 1 or 2), and frailty (frailty point 3 or more) were observed in 63 (34.4%), 98 (53.6%), and 22 (12.0%) of males, respectively, and 63 (32.8%), 101 (52.6%), and 28 (14.6%) of females, respectively. In receiver operating characteristics (ROC) curve analyses for the presence of frailty, CC had the highest area under the ROC (AUC) both in male (AUC = 0.693, cutoff point = 33.7 cm) and female (AUC = 0.734, cutoff point = 33.4 cm) participants. In the multivariate analysis associated with frailty, for the male participants, only the presence of liver cirrhosis (p = 0.0433) was identified to be significant, while among the female participants, serum albumin (p = 0.0444) and CC (p = 0.0010) were identified to be significant. In conclusion, CC can be helpful for predicting frailty, especially in female CLD patients.
format Online
Article
Text
id pubmed-7344770
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73447702020-07-09 Anthropometric Measurements and Frailty in Patients with Liver Diseases Nishikawa, Hiroki Yoh, Kazunori Enomoto, Hirayuki Ikeda, Naoto Aizawa, Nobuhiro Koriyama, Takashi Nishimura, Takashi Nishiguchi, Shuhei Iijima, Hiroko Diagnostics (Basel) Article There have been scarce data regarding the relationship between frailty and anthropometry measurements (AMs) in patients with chronic liver diseases (CLDs). We aimed to elucidate the influence of AMs on frailty in CLDs (median age = 66 years, 183 men and 192 women). AMs included arm circumference, triceps skinfold thickness, calf circumference (CC), waist circumference, and body mass index. Frailty assessment was done by using five phenotypes (body weight loss, exhaustion, decreased muscle strength, slow walking speed, and low physical activity). Robust (frailty point 0), prefrail (frailty point 1 or 2), and frailty (frailty point 3 or more) were observed in 63 (34.4%), 98 (53.6%), and 22 (12.0%) of males, respectively, and 63 (32.8%), 101 (52.6%), and 28 (14.6%) of females, respectively. In receiver operating characteristics (ROC) curve analyses for the presence of frailty, CC had the highest area under the ROC (AUC) both in male (AUC = 0.693, cutoff point = 33.7 cm) and female (AUC = 0.734, cutoff point = 33.4 cm) participants. In the multivariate analysis associated with frailty, for the male participants, only the presence of liver cirrhosis (p = 0.0433) was identified to be significant, while among the female participants, serum albumin (p = 0.0444) and CC (p = 0.0010) were identified to be significant. In conclusion, CC can be helpful for predicting frailty, especially in female CLD patients. MDPI 2020-06-25 /pmc/articles/PMC7344770/ /pubmed/32630551 http://dx.doi.org/10.3390/diagnostics10060433 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nishikawa, Hiroki
Yoh, Kazunori
Enomoto, Hirayuki
Ikeda, Naoto
Aizawa, Nobuhiro
Koriyama, Takashi
Nishimura, Takashi
Nishiguchi, Shuhei
Iijima, Hiroko
Anthropometric Measurements and Frailty in Patients with Liver Diseases
title Anthropometric Measurements and Frailty in Patients with Liver Diseases
title_full Anthropometric Measurements and Frailty in Patients with Liver Diseases
title_fullStr Anthropometric Measurements and Frailty in Patients with Liver Diseases
title_full_unstemmed Anthropometric Measurements and Frailty in Patients with Liver Diseases
title_short Anthropometric Measurements and Frailty in Patients with Liver Diseases
title_sort anthropometric measurements and frailty in patients with liver diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344770/
https://www.ncbi.nlm.nih.gov/pubmed/32630551
http://dx.doi.org/10.3390/diagnostics10060433
work_keys_str_mv AT nishikawahiroki anthropometricmeasurementsandfrailtyinpatientswithliverdiseases
AT yohkazunori anthropometricmeasurementsandfrailtyinpatientswithliverdiseases
AT enomotohirayuki anthropometricmeasurementsandfrailtyinpatientswithliverdiseases
AT ikedanaoto anthropometricmeasurementsandfrailtyinpatientswithliverdiseases
AT aizawanobuhiro anthropometricmeasurementsandfrailtyinpatientswithliverdiseases
AT koriyamatakashi anthropometricmeasurementsandfrailtyinpatientswithliverdiseases
AT nishimuratakashi anthropometricmeasurementsandfrailtyinpatientswithliverdiseases
AT nishiguchishuhei anthropometricmeasurementsandfrailtyinpatientswithliverdiseases
AT iijimahiroko anthropometricmeasurementsandfrailtyinpatientswithliverdiseases